Shandong Sinobioway Biomedicine (SHE:002581), through unit Shandong Yandu Biotechnology, signed a 54 million yuan purchase deal to buy materials for its human nerve growth factor eye drops, according to a Shenzhen Stock Exchange disclosure on Wednesday.
Under the deal, Yandu Biotechnology will purchase storage liquid and chromatography systems, fillers, and reaction bags from Jiangsu Suhao Innovation Technology Group, the Chinese pharmaceutical company said.
The amount included nearly 14 million yuan for the fillers and reaction bags and around 40 million yuan for the storage liquid and chromatography systems.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。